KTTAW
Pasithea Therapeutics Corp. WarrantNASDAQ
Updated 8 days ago
Coverage limited
$0.00-6.67%
Close Sep 15, 2026
- Market cap
- —
- 1 month
- —
- 3 months
- —
- 1 year
- —
- 52-week range
- $0.00$0.06
- Dividend
- No dividends on record
- Short interest
- 26.8K sharessettled Sep 15, 2026 · -1.5% since Aug 31, 2026 · FINRA
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if KTTAW is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: LOW
1 top institutions tracked
as of 2026-Q2 (filed 2026-08-14)
Insider context
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
Largest 13-F holders · Q2 2026
6 filers reported a long position in KTTAW for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Kepos Capital LP | $2K | 334.6K | Unchanged |
| TWO SIGMA SECURITIES, LLC | $397 | 57.5K | +3.4% |
| ARMISTICE CAPITAL, LLC | $345 | 50K | Unchanged |
| Marex Group Ltd | $223 | 25K | Unchanged |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $216 | 24.3K | New |
| Clear Street Group Inc. | $3 | 380 | New |
Get the Full Analysis for KTTAW
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.